MacroGenics ROA 2012-2019 | MGNX

Current and historical return on assets (ROA) values for MacroGenics (MGNX) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets. MacroGenics ROA for the three months ending September 30, 2019 was -44.82%.
MacroGenics ROA - Return on Assets Historical Data
Date TTM Net Income Total Assets Return on Assets
2019-09-30 $-0.17B $0.35B -45.07%
2019-06-30 $-0.16B $0.38B -41.99%
2019-03-31 $-0.17B $0.42B -44.86%
2018-12-31 $-0.17B $0.33B -49.14%
2018-09-30 $-0.02B $0.36B -5.83%
2018-06-30 $-0.03B $0.39B -10.23%
2018-03-31 $-0.03B $0.33B -10.52%
2017-12-31 $-0.02B $0.37B -6.86%
2017-09-30 $-0.16B $0.24B -58.39%
2017-06-30 $-0.15B $0.28B -49.29%
2017-03-31 $-0.07B $0.28B -20.69%
2016-12-31 $-0.06B $0.31B -17.53%
2016-09-30 $-0.05B $0.34B -14.92%
2016-06-30 $-0.03B $0.37B -9.18%
2016-03-31 $-0.09B $0.33B -28.42%
2015-12-31 $-0.02B $0.36B -5.96%
2015-09-30 $-0.01B $0.38B -3.67%
2015-06-30 $0.00B $0.25B 0.44%
2015-03-31 $0.01B $0.28B 4.69%
2014-12-31 $-0.04B $0.17B -19.39%
2014-09-30 $-0.02B $0.19B -8.70%
2014-06-30 $-0.01B $0.21B -8.22%
2014-03-31 $0.00B $0.21B 0.00%
2013-12-31 $0.00B $0.13B 0.00%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.593B $0.060B
MacroGenics Inc. is a biopharmaceutical company. It is focused on discovering and developing innovative monoclonal antibody-based therapeutics. The Company has a diverse portfolio of product candidates focused in three therapeutic areas: oncology, autoimmune disorders and infectious diseases. MacroGenics Inc. is headquartered in Rockville, Maryland.
Stock Name Country Market Cap PE Ratio
Medtronic (MDT) Ireland $161.274B 22.28
Abbott Laboratories (ABT) United States $158.684B 28.94
Stryker (SYK) United States $80.301B 27.00
Boston Scientific (BSX) United States $61.426B 28.99
Baxter (BAX) United States $46.496B 28.19
Essilor Luxottica (ESLOY) France $34.560B 0.00
Zimmer Biomet Holdings (ZBH) United States $30.746B 19.29
Lonza Group Ag (LZAGY) Switzerland $30.251B 0.00
Coloplast (CLPBY) Denmark $27.680B 42.72
Terumo (TRUMY) Japan $27.077B 33.79
ResMed (RMD) United States $23.285B 42.96
Smith & Nephew SNATS (SNN) United Kingdom $21.640B 0.00
Sunny Optical Technology (SNPTF) China $20.017B 0.00
Insulet (PODD) United States $11.805B 561.62
Bio-Rad Laboratories (BIO) United States $11.341B 54.44
Canopy Growth (CGC) Canada $8.423B 0.00
Perrigo (PRGO) Ireland $8.143B 15.19
William Demant Holdings (WILYY) Denmark $7.896B 0.00
Hill-Rom Holdings (HRC) United States $7.709B 22.67
DiaSorin S.p.A (DSRLF) Italy $7.357B 0.00
GN STORE NORD (GNNDY) Denmark $6.158B 31.81
Haemonetics (HAE) United States $5.850B 39.53
Shandong Weigao Medical Polymer (SHWGF) China $5.020B 0.00
NuVasive (NUVA) United States $4.044B 31.84
ICU Medical (ICUI) United States $3.943B 25.70
Hutchison China MediTech (HCM) Hong Kong, SAR China $3.936B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $3.739B 0.00
Neogen (NEOG) United States $3.653B 60.79
Agios Pharmaceuticals (AGIO) United States $3.168B 0.00
Quidel (QDEL) United States $3.079B 29.22
National Vision Holdings (EYE) United States $2.673B 60.32
Aurora Cannabis (ACB) Canada $2.190B 0.00
Cardiovascular Systems (CSII) United States $1.907B 0.00
AtriCure (ATRC) United States $1.529B 0.00
InMode (INMD) Israel $1.502B 0.00
TG Therapeutics (TGTX) United States $1.394B 0.00
Aphria (APHA) $1.344B 0.00
VAREX IMAGING (VREX) United States $1.198B 23.95
NanoString Technologies (NSTG) United States $1.069B 0.00
Phibro Animal Health (PAHC) United States $1.038B 19.45
PetIQ (PETQ) United States $0.833B 20.33
Eagle Pharmaceuticals (EGRX) United States $0.798B 30.56
LeMaitre Vascular (LMAT) United States $0.739B 41.52
Lantheus Holdings (LNTH) United States $0.735B 18.35
Quanterix (QTRX) United States $0.704B 0.00
Omeros (OMER) United States $0.670B 0.00
Cerus (CERS) United States $0.629B 0.00
Surmodics (SRDX) United States $0.558B 57.89
OraSure Technologies (OSUR) United States $0.502B 30.11
Organigram Holdings (OGI) Canada $0.492B 0.00
Meridian Bioscience (VIVO) United States $0.416B 14.28
Owens & Minor (OMI) United States $0.409B 15.12
HEXO (HEXO) $0.405B 0.00
Utah Medical Products (UTMD) United States $0.388B 28.14
Zynex (ZYXI) United States $0.347B 39.30
BioLife Solutions (BLFS) United States $0.320B 130.50
Female Health (VERU) United States $0.297B 0.00
Neptune Wellness Solutions (NEPT) Canada $0.290B 0.00
Bovie Medical (APYX) United States $0.281B 0.00
Vapotherm (VAPO) United States $0.248B 0.00
Repro-Med Systems (KRMD) United States $0.246B 0.00
United Health Products (UEEC) United States $0.230B 0.00
Viemed Healthcare (VMD) United States $0.209B 22.00
Liberty Health Sciences (LHSIF) Canada $0.175B 0.00
InfuSystems Holdings (INFU) United States $0.173B 872.00
Green Organic Dutchman Holdings (TGODF) Canada $0.173B 0.00
Rockwell Medical (RMTI) United States $0.156B 0.00
Cytosorbents (CTSO) United States $0.148B 0.00
Fonar (FONR) United States $0.135B 9.49
Chimerix (CMRX) United States $0.128B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.097B 0.00
Surface Oncology (SURF) United States $0.091B 0.00
MTech Acquisition (KERN) United States $0.089B 0.00
United-Guardian (UG) United States $0.087B 21.90
MRI Interventions (MRIC) United States $0.080B 0.00
Nephros (NEPH) United States $0.078B 0.00
Chembio Diagnostics (CEMI) United States $0.071B 0.00
FSD PHARMA INC (HUGE) $0.053B 0.00
ImmuCell (ICCC) United States $0.043B 0.00
Trinity Biotech (TRIB) Ireland $0.030B 0.00
GUARDION HEALTH (GHSI) United States $0.026B 0.00
NF Energy Saving (BIMI) China $0.025B 0.00
Senestech (SNES) United States $0.017B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.015B 0.00
Capricor Therapeutics (CAPR) United States $0.008B 0.00
Valeritas Holdings (VLRX) United States $0.007B 0.00
Myomo (MYO) United States $0.005B 0.00
NeuroMetrix (NURO) United States $0.004B 0.00
Akers Biosciences Inc (AKER) United States $0.002B 0.00